NextFin news, Researchers at Johns Hopkins University in Baltimore, Maryland, announced this Tuesday that a novel MRI technique can predict the onset of mild cognitive impairment (MCI) and cognitive decline by measuring iron levels in the brain.
The technique, known as Quantitative Susceptibility Mapping (QSM) MRI, is a non-invasive brain scan that detects iron accumulation in specific brain regions associated with memory and cognition. Elevated brain iron levels have been linked to neurodegenerative diseases such as Alzheimer's disease.
The study, published on Tuesday, September 9, 2025, demonstrated that higher iron concentrations in the brain could serve as an early biomarker for dementia risk years before clinical symptoms appear. This allows for earlier diagnosis and potential intervention.
The research team conducted brain scans on participants and correlated iron levels with cognitive assessments over time. Their findings showed that individuals with increased brain iron were more likely to experience memory loss and cognitive decline.
This advancement offers a promising tool for clinicians to identify patients at risk of dementia earlier than current methods allow. The study was reported by News-Medical and the Times of India, citing the Johns Hopkins research.
The MRI technique's ability to map brain iron provides a new avenue for understanding the biological changes preceding cognitive impairment and may guide future therapeutic strategies.
Explore more exclusive insights at nextfin.ai.